Drug Development: Molecular Targets for GI Diseases - Image 1

£74.95

Humana Drug Development: Molecular Targets for GI Diseases

Name: Drug Development: Molecular Targets for GI Diseases
Brand: Humana
Price: 74.95 GBP
Availability: InStock

Pharmacy - Dispensing

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£75 today · all-time low £74 (May 2026) · usually £75

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days • 61 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 61 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £76 (40 days, 65.6%)

Price range: £74 - £76

Price levels: 3 different prices over 61 days

Description

The application of molecular techniques to gastroenterology continues to yield important advances in the development of drugs to treat gastrointestinal disorders. Important new drugs have emerged through the collaborative and complementary efforts of basic scientists, clinicians, and clinical researchers in academia and the pharmaceutical industry. The challenge has been exciting, with a few surprises along the way. Consider peptic ulcer disease as an example. The discovery of H receptors and the availability of potent and 2 selective H-receptor antagonists signaled the beginning of a new era 2 in the treatment of gastric hypersecretory states and peptic ulcers. Introduction of proton pump inhibitors offered another therapeutic option. Though H-receptor antagonists and proton pump inhibitors 2 are important and useful drugs, the discovery of the link between H. pylori infection and peptic ulcer disease has led to even more effective pharmacotherapeutic regimens. Our intent in Drug Development: Molecular Targets for GI Diseases is to bring together hands-on experts to review promising areas of gastrointestinal pharmacology. The contemporary topics covered, from a mechanistic viewpoint, are relevant to gastrointestinal inflammation and motility disorders. Authoritative opinions are offered on both future research directions and potential applications for new therapies. Review "The book focuses on specific molecules and the drugs that act on them, their receptors, metabolism or synthesis. . . a useful text for investigators of GI function and for pharmacologists interested in therapeutic compounds, their actions and targets."-Trends in Pharmaceutical Sciences From the Back Cover Drug Development: Molecular Targets for Gastrointestinal Disease brings together a panel of distinguished experts to critically review the many promising new areas of gastrointestinal pharmacology at the molecular level. Key chapters discuss such major themes as the cyclooxygenase-2 inhibitors, the complexities of nitric oxide pathways in the gut, and the influence of cytokines on inflammatory bowel disease, as well as new opportunities for pharmacotherapy, including peptide growth factors, tachykinins-particularly substance P and neurokinins-cholecystokinin receptors, and serotonin. Also examined as possible sites for treating motility disorders and visceral pain are the opioid receptors residing in the gut, and the H3-receptor agonists for treating gut inflammation and pain. Drug Development: Molecular Targets for Gastrointestinal Disease provides a comprehensive review of today's molecular pharmacological approaches to the discovery and development of novel drugs for gastrointestinal and liver diseases. Its extensive references, richly experienced contributors, and cutting-edge syntheses of past, present, and emergent research establish the book as an essential resource for all pharmacologists, medicinal chemists, and clinicians seeking more powerful drugs for the prevention and treatment of gastrointestinal disorders.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617370878
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 05 November 2010
Listed Since: 11 July 2010

Barcode

No barcode data available

Humana Drug Development: Molecular Targets for GI Diseases

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cardiac Drug Development Guide (Methods in Pharmacology and Toxicology)

Pharmacotherapy of Gastrointestinal Inflammation (Progress in Inflammation Research)

Pharmacology of Peptic Ulcer Disease: 99 (Handbook of Experimental Pharmacology, 99)

Diseases of the Gastroesophageal Mucosa: The Acid-Related Disorders (Clinical Gastroenterology)

Introduction to Gastrointestinal Diseases Vol. 1

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Anti-Obesity Drug Development: Physiology, Pharmacology and Drug Delivery

Drug-Induced Liver Toxicity (Methods in Pharmacology and Toxicology)

Human Drug Targets: A Compendium for Pharmaceutical Discovery

Kinase Inhibitors: Methods and Protocols: 795 (Methods in Molecular Biology, 795)

Insights into Receptor Function and New Drug Development Targets (Research and Perspectives in Endocrine Interactions)

Prokineticins: From the Gastrointestinal Tract to Neuroinflammation (Molecular Mediators in Health and Disease: How Cells Communicate)

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Target Discovery and Validation Reviews and Protocols: Emerging Strategies for Targets and Biomarker Discovery, Volume 1: 360 (Methods in Molecular Biology)

Biopharmaceutical Drug Design and Development

Optimization in Drug Discovery (Methods in Pharmacology and Toxicology)

Drug Design and Discovery: Methods and Protocols: 716 (Methods in Molecular Biology, 716)

Innovations en médecine hépatique et gastro-intestinale

Cancer Prevention: Dietary Factors and Pharmacology (Methods in Pharmacology and Toxicology)

Green Chemistry in Drug Discovery: From Academia to Industry (Methods in Pharmacology and Toxicology)

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Computational Drug Discovery and Design: 1762 (Methods in Molecular Biology, 1762)

Functional Selectivity of G Protein-Coupled Receptor Ligands: New Opportunities for Drug Discovery (The Receptors)

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)